Improving PRegnancy Outcomes With Intermittent preVEntive Treatment in Africa
Status:
Completed
Trial end date:
2020-03-15
Target enrollment:
Participant gender:
Summary
This study evaluates the efficacy and safety of monthly intermittent preventive treatment
using dihydroartemisinin piperaquine (DP) alone or in combination with azithromycin (AZ)
compared to sulphadoxine-pyrimethamine (SP) for the prevention of malaria in pregnant women
in the second and third trimester.
Phase:
Phase 3
Details
Lead Sponsor:
Liverpool School of Tropical Medicine
Collaborators:
Centers for Disease Control and Prevention Foundation for Innovative New Diagnostics, Switzerland Kenya Medical Research Institute Kilimanjaro Christian Medical Centre, Tanzania London School of Hygiene and Tropical Medicine Malawi-Liverpool-Wellcome Trust Clinical Research Programme National Institute for Medical Research, Tanzania PATH Tampere University University College, London University of Bergen University of Copenhagen University of Malawi College of Medicine University of Massachusetts, Worcester University of Melbourne University of Toronto